October 28, 2025 — Pleural Dynamics, Inc. today announced positive results from a prospective, multicenter study evaluating its Automatic Continuous Effusion Shunt (ACES) device for the management of symptomatic recurrent pleural effusions. The study, presented at the CHEST 2025 Annual Meeting, demonstrated that implantation of the ACES device resulted in a 53% median reduction in pleural effusion volume at 30 days, with no adverse events related to fluid diversion to the abd

October 14, 2025 --The Centers for Medicare and Medicaid Services (CMS) has issued a new Healthcare Common Procedure Coding System (HCPCS) code and New Technology Ambulatory Payment Classification (New Technology APC) assignment for the ACES (Automatic Continuous Effusion Shunt) device to treat chronic pleural effusions. The new code issued is C8006: Insertion of pleural-peritoneal shunt with intercostal pump chamber, including imaging, injection(s) of contrast with radiolog

Aug 19, 2025 Pleural Dynamics Announces Completion of Enrollment of “The ACES Study for Aseptic Pleural Effusions,” a Post Market Study...